Mark Lawler: Time to defuse the ticking time bomb
Mark Lawler shared a post by The Lancet Oncology on X, adding:
“Time to defuse the ticking time bomb! Lets reinstate a national cancer plan and reinvigorate our cancer research UK-wide. Let’s use evidence, not opinion in the key decisions that are critical for our citizens We want to be leaders, not laggers.”
Quoting The Lancet Oncology’s post:
“UK cancer care ‘lags behind’ other countries as experts highlight ‘ticking time bomb’.”
Additional information
Source: Mark Lawler/X and The Lancet Oncology/X
Dr. Mark Lawler is the Chair in Translational Cancer Genomics and the Associate Director of Postgraduate Studies at Queen’s University Belfast, Centre for Cancer Research and Cell Biology.
He is also a Visiting Professor in Human Genetics and Molecular Medicine at the University of Chieti Pescara, Italy. His specialties include genetics, molecular medicine, cancer biology, drug discovery, graduate education, bioethics, science policy, art therapy, and public perception of science.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023